Metformin and rapamycin have distinct effects on the AKT pathway and proliferation in breast cancer cells

Author： Zakikhani Mahvash   Blouin Marie-José   Piura Esther   Pollak Michael  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.1, 2010-08, pp. : 271-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway

By      

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 1828-1836

Spandidos Publications

Access to resources Recommend Favorite

Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway

By          

Experimental and Therapeutic Medicine, Vol. 9, Iss. 4, 2015-01 ,pp. : 1401-1406

Spandidos Publications

Access to resources Recommend Favorite

PP242 suppresses bladder cancer cell proliferation and migration through deactivating the mammalian target of rapamycin complex 2/AKT1 signaling pathway

By Zhang Zhe   Zhang Guojun   Kong Chuize   Gong Daxin  

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 333-338

Spandidos Publications

Access to resources Recommend Favorite

MicroRNA-147 suppresses proliferation, invasion and migration through the AKT/mTOR signaling pathway in breast cancer

By      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 405-410

Spandidos Publications

Access to resources Recommend Favorite

Fucoidan inhibits the migration and proliferation of HT-29 human colon cancer cells via the phosphoinositide-3 kinase/Akt/mechanistic target of rapamycin pathways

By      

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3446-3452

Spandidos Publications

Access to resources Recommend Favorite